妇科癌症患者的非特异性白细胞游走抑制
Non-specific leucocyte migration inhibition of gynaecological carcinoma patients.
作者信息
Tosner J, Fixa B
出版信息
Clin Exp Immunol. 1979 Nov;38(2):356-60.
Abstract
Leucocyte migration inhibition in the presence of tumour crude ovarian tissue antigen was demonstrated in 64.51% of ovarian cancer patients, in 58.18% of other gynaecological carcinoma patients and in 19.04% of healthy individuals. Patients with benign ovarian disease showed 12.5% leucocyte migration inhibition. No significant difference was seen between results obtained in the presence of ovarian carcinoma antigen and normal ovary antigen.
摘要
在存在肿瘤粗制卵巢组织抗原的情况下，64.51%的卵巢癌患者、58.18%的其他妇科癌症患者以及19.04%的健康个体出现了白细胞迁移抑制。患有良性卵巢疾病的患者白细胞迁移抑制率为12.5%。在存在卵巢癌抗原和正常卵巢抗原的情况下所获得的结果之间未观察到显著差异。
相似文献
1
Non-specific leucocyte migration inhibition of gynaecological carcinoma patients.妇科癌症患者的非特异性白细胞游走抑制
Clin Exp Immunol. 1979 Nov;38(2):356-60.
2
[Studies on tumor-specific immune response evaluated by leucocyte migration inhibition test under agarose-plate in gynecological malignancy (author's transl)].琼脂平板下白细胞游走抑制试验评估妇科恶性肿瘤中肿瘤特异性免疫反应的研究（作者译）
Acta Obstet Gynaecol Jpn. 1981 Jul;33(7):1015-24.
3
[The utilisation of the leukocyte migration inhibition test (L.M.T) in carcinoma of cervix uteri (author's transl)].白细胞移动抑制试验（L.M.T）在子宫颈癌中的应用（作者译）
Arch Geschwulstforsch. 1980;50(2):169-72.
4
[Leukocyte migration inhibition in women with tumors in an environment with ovarian carcinoma antigen and encephalitogenic factor].[卵巢癌抗原和致脑炎因子环境中肿瘤女性的白细胞迁移抑制]
Cas Lek Cesk. 1984 Mar 23;123(12):354-7.
5
6
7
Inhibition of leukocyte migration in agar by soluble extract from a human ovarian carcinoma cell line.人卵巢癌细胞系可溶性提取物对琼脂中白细胞迁移的抑制作用
Jpn J Exp Med. 1982 Jun;52(3):119-24.
8
Leucocyte migration inhibition test in patients with gynaecologic malignancy.妇科恶性肿瘤患者的白细胞游走抑制试验
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove. 1981;24(4):415-89.
9
A sequential study of humoral factors in ovarian neoplasms.卵巢肿瘤体液因子的序贯研究。
Indian J Pathol Microbiol. 1994 Jul;37(3):319-26.
10
Formalinized tumour cells in the leucocyte migration inhibition test.白细胞游走抑制试验中的甲醛固定肿瘤细胞。
Clin Exp Immunol. 1975 Oct;22(1):126-32.
本文引用的文献
1
Human lymphocyte migration as a parameter of hypersensitivity.人类淋巴细胞迁移作为超敏反应的一个参数。
Acta Med Scand. 1967 Feb;181(2):247-56. doi: 10.1111/j.0954-6820.1967.tb07255.x.
2
Cellular immunity as a host response to squamous carcinoma of the cervix.细胞免疫作为宿主对宫颈癌的反应。
Am J Obstet Gynecol. 1971 Nov;111(6):751-5. doi: 10.1016/0002-9378(71)90484-4.
3
Antibody cytotoxicity studies in ovarian and cervical malignancies.卵巢癌和宫颈癌中的抗体细胞毒性研究。
Obstet Gynecol. 1973 Nov;42(5):644-50.
4
Tumor-specific antigens and reexpression of fetal antigens in mammalian cells.哺乳动物细胞中的肿瘤特异性抗原和胎儿抗原的重新表达。
Prog Exp Tumor Res. 1974;19:45-58. doi: 10.1159/000395848.
5
Cell-mediated immunity in patients with ovarian carcinoma.卵巢癌患者的细胞介导免疫
Am J Obstet Gynecol. 1973 Feb 15;115(4):467-70. doi: 10.1016/0002-9378(73)90392-x.
6
In vitro lymphocyte stimulation by a soluble antigen from malignant melanoma.恶性黑色素瘤可溶性抗原对淋巴细胞的体外刺激作用。
N Engl J Med. 1970 Aug 13;283(7):329-33. doi: 10.1056/NEJM197008132830702.
7
An immunologic comparison between serous cystadenocarcinoma of the ovary and other human gynecologic tumors.卵巢浆液性囊腺癌与其他人类妇科肿瘤的免疫学比较。
Am J Obstet Gynecol. 1973 Nov 15;117(6):849-53. doi: 10.1016/0002-9378(73)90501-2.
8
Quantitation of antigens in normal and malignant ovarian tissue.正常和恶性卵巢组织中抗原的定量分析。
Am J Obstet Gynecol. 1975 Oct 1;123(3):302-4. doi: 10.1016/0002-9378(75)90203-3.
9
Cellular hypersensitivity in patients with squamous cell carcinoma of the cervix.子宫颈鳞状细胞癌患者的细胞超敏反应。
Am J Obstet Gynecol. 1975 Jan 1;121(1):91-5. doi: 10.1016/0002-9378(75)90981-3.
10
Circulatory and cellular immune responses to squamous cell carcinoma of the uterine cervix.子宫颈鳞状细胞癌的循环和细胞免疫反应。
Am J Obstet Gynecol. 1976 Sep 1;126(1):116-21. doi: 10.1016/0002-9378(76)90475-0.
Zotero 插件